Clinical Trials Browser

Phase 1/2 × Terminated × Diabetes Mellitus, Insulin-Dependent, 12 × Clear all

NCT03013491 2025-06-17

PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

Phase 1/2 Terminated

196 enrolled 28 charts

Diabetes Mellitus, Insulin-Dependent, 12, Lymphoma, Neoplasms

NCT03116529 2024-11-04

NEXIS

Phase 1/2 Terminated

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Sarcoma

NCT03354962 2020-12-04

Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA)

Phase 1/2 Terminated

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma